1000339-35-4

Basic information

• Product Name: 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE
• Synonyms: 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE;5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULPHONAMIDE
• CAS NO: 1000339-35-4
• Molecular Formula: C₁₀H₁₂BrNO₃S
• Molecular Weight: 306.18
• Mol File: 1000339-35-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE(1000339-35-4)
• EPA Substance Registry System: 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE(1000339-35-4)

Safety Data

• Hazardous Substances Data: 1000339-35-4(Hazardous Substances Data)

Usage

General Description

5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE is a chemical compound that is commonly used in pharmaceutical research and drug development. It belongs to the category of sulfonamide compounds, which are known for their various biological activities. This particular compound has a cyclopropyl group and a methoxy group attached to a benzene ring, as well as a bromine atom. Its structure and properties make it a potentially important building block for designing new drugs with targeted activities. Researchers are interested in exploring its potential as an anti-cancer, anti-inflammatory, or anti-bacterial agent. Overall, 5-BROMO-N-CYCLOPROPYL-2-METHOXYBENZENESULFONAMIDE has significant potential in the field of medicinal chemistry and drug discovery.

Upstream product

• 104-92-7 1-bromo-4-methoxy-benzene 
• 23095-05-8 5-bromo-2-methoxybenzenesulfonyl chloride 
• 765-30-0 Cyclopropylamine 

Downstream Products

• 1355554-26-5 N-cyclopropyl-5-(3,5-dimethyl-4-isoxazolyl)-2-(methyloxy)benzenesulfonamide 
• 1443151-92-5 N-cyclopropyl-5(4-[[2-(4-fluorophenyl)ethyl]amino]-6-methoxy-1,3,5-triazin-2-yl)-2-methoxybenzenesulfonamide 

Relevant articles and documents

1,3,5-TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF

The present invention relates to compounds corresponding to formula (I) in which: - R1 represents a substituted phenyl; - R2 represents: - a substituted phenyl; - a heteroaromatic group, the said group being unsubstituted or substituted one or more times; - R3 represents a group Alk; - R4 represents a hydrogen atom or a (C1-C4)alkyl; - R5 represents a hydrogen atom, a (C3-C6)cycloalkyl or a (C1-C4)alkyl-O-Alk; - or alternatively R4 and R5, together with the nitrogen atom to which they are attached, constitute a heterocyclic radical chosen from: azetidin-1-yl, pyrrolidin-1-yl, piperid-1-yl, morpholin-4-yl; - R6 represents a group -COOAlk, a group -CONH2 or a group -NHSO2 Alk; - Alk represents a (C1-C4)alkyl, which is unsubstituted or substituted one or more times with a halogen atom; in the form of the base or of an acid-addition salt. Preparation process and diagnostic and therapeutic use